Buys
Open market- Shares
- Avg price
- Total value
Christopher Durant Turner - Chief Medical Officer at Nuvalent, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Medical Officer
- Issuer Symbol
- NUVL on Nasdaq
- All Insider Reports
- All Insider Reports
Christopher Durant Turner - trading volume in the past year for Nuvalent, Inc.
Sells
Open market- Shares
- -7,417
- Avg price
- $97.25
- Total value
- -$721,320
Net
Past year- Shares
- -7,417
- Share %
- -100%
- Total value
- -$721,320
Holdings reported by Christopher Durant Turner for Nuvalent, Inc.
Form 4 holding
Chief Medical Officer
Nuvalent, Inc.
- Security class
- Class A Common Stock
- Shares / value
- 72,630
- Estimated value
- $7,305,924
- Report date
- 07 Jan 2026
- Price
- $100.59
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
Nuvalent, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 17,500
- Estimated value
- Report date
- 07 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
Transactions reported by Christopher Durant Turner for Nuvalent, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.